Laboratorios Richmond SACIF

Laboratorios Richmond SACIF OCF Margin

The Operating Cash Flow Margin of Laboratorios Richmond SACIF (RICH.BA) as of Nov 22, 2026 is 6.13 %. In the previous year, Operating Cash Flow Margin was -6.42 % — a change of -195.40% (higher).

OCF Margin

6.13 %

YoY

-195.40%

Last updated:

Operating Cash Flow Margin of Laboratorios Richmond SACIF is 2024 6.13 % . Operating Cash Flow Margin of Laboratorios Richmond SACIF was 2023 -6.42 % . It decreases by -195.40% higher compared to the previous year.

The Laboratorios Richmond SACIF OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2017
0.70 ARS
Jan 1, 2018
-6.52 ARS
Jan 1, 2019
2.28 ARS
Jan 1, 2020
-1.94 ARS
Jan 1, 2021
22.47 ARS
Jan 1, 2022
-23.20 ARS
Jan 1, 2023
-6.42 ARS
Jan 1, 2024
6.13 ARS
The Laboratorios Richmond SACIF OCF Margin history
YEAROCF MarginYoY
6.13 %-195.40%
-6.42 %-72.33%
-23.20 %-203.25%
22.47 %-1,256.28%
-1.94 %-185.16%
2.28 %-135.02%
-6.52 %-1,028.01%
0.70 %-263.74%
-0.43 %-92.47%
-5.70 %+70.61%
-3.34 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Laboratorios Richmond SACIF Stock analysis

What does Laboratorios Richmond SACIF do? Laboratorios Richmond SACIF is a specialized pharmaceutical company focused on the manufacturing and marketing of medications. It was founded in 1935 and is headquartered in Buenos Aires, Argentina. The company has extensive experience in the development of medications and biological products, with expertise in pharmaceutical research and development. It has various business divisions including generics, biological medications, vaccines, oncology medications, and medical devices. The company's products range from simple painkillers and antihistamines to important medications for treating cancer and HIV. Richmond SACIF also manufactures vaccines against diseases such as Hepatitis A and B, polio, influenza, tetanus, and other infectious diseases. Additionally, the company produces a wide range of medications for treating different types of cancer and offers medical instruments and surgical devices. Its business model focuses on innovation and meeting the needs of patients, investing in research and development to develop new and innovative products. The company also has strict quality control measures to ensure the highest pharmaceutical standards. With its rich history and broad range of products, Laboratorios Richmond SACIF is a key player in the global pharmaceutical market and will continue to play an important role in improving the health of people worldwide. Laboratorios Richmond SACIF is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Laboratorios Richmond SACIF stock

Operating Cash Flow Margin of Laboratorios Richmond SACIF is 6.13 % in 2024.

Operating Cash Flow Margin of Laboratorios Richmond SACIF changed from -6.42 % to 6.13 %, representing a -195.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Laboratorios Richmond SACIF since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Laboratorios Richmond SACIF with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Laboratorios Richmond SACIF

All Key Metrics — Laboratorios Richmond SACIF